Afya Limited (NASDAQ:AFYA) Short Interest Up 32.4% in December

Afya Limited (NASDAQ:AFYA) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling 361,326 shares, an increase of 32.4% from the December 15th total of 272,979 shares. Based on an average daily volume of 105,049 shares, the short-interest ratio is presently 3.4 days. Approximately 0.4% of the company’s shares are sold short. Approximately 0.4% of the company’s shares are sold short. Based on an average daily volume of 105,049 shares, the short-interest ratio is presently 3.4 days.

Institutional Trading of Afya

Institutional investors and hedge funds have recently bought and sold shares of the company. Doma Perpetual Capital Management LLC grew its holdings in shares of Afya by 50.6% during the third quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after buying an additional 299,419 shares during the last quarter. SPX Gestao de Recursos Ltda bought a new position in Afya in the 3rd quarter valued at approximately $2,895,000. Perpetual Ltd boosted its stake in Afya by 1.8% during the 2nd quarter. Perpetual Ltd now owns 151,180 shares of the company’s stock valued at $2,700,000 after purchasing an additional 2,730 shares during the last quarter. Carrera Capital Advisors bought a new stake in shares of Afya in the 2nd quarter worth $1,750,000. Finally, GSA Capital Partners LLP raised its stake in shares of Afya by 45.5% in the third quarter. GSA Capital Partners LLP now owns 89,747 shares of the company’s stock worth $1,400,000 after purchasing an additional 28,053 shares during the last quarter. 88.02% of the stock is currently owned by institutional investors.

Afya Stock Down 3.2%

AFYA stock opened at $13.93 on Friday. The business has a 50 day moving average of $14.78 and a 200 day moving average of $15.02. The firm has a market cap of $1.31 billion, a PE ratio of 10.02, a price-to-earnings-growth ratio of 0.52 and a beta of 0.53. Afya has a twelve month low of $13.12 and a twelve month high of $19.90. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.21.

Wall Street Analyst Weigh In

AFYA has been the subject of a number of research reports. Zacks Research downgraded shares of Afya from a “hold” rating to a “strong sell” rating in a research note on Friday, January 9th. Wall Street Zen raised Afya from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 10th. JPMorgan Chase & Co. restated a “neutral” rating and set a $22.00 price target (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. UBS Group reiterated a “neutral” rating and issued a $16.00 price objective (down previously from $18.00) on shares of Afya in a report on Friday. Finally, Sanford C. Bernstein raised Afya to a “market perform” rating in a research report on Friday. One research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Afya currently has an average rating of “Hold” and a consensus target price of $17.38.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.